CORRELATION OF ATHEROGENIC INDEX OF PLASMA WITH STENOSIS LEVEL OF CORONARY ARTERY IN ACUTE CORONARY SYNDROME
DOI:
https://doi.org/10.24293/ijcpml.v25i1.1491Keywords:
Acute coronary syndrome, atherogenic index plasma, stenosis levelAbstract
Atherogenic dyslipidemia is the main risk factor of Acute Coronary Syndrome (ACS), caused atherosclerosis plaque and stenosis of artery coronary. Lipid profile ratio used as a marker of cardiovascular disease severity. Atherogenic Index of Plasma (AIP) calculated as logarithm triglycerides/high-density lipoprotein cholesterol (TG/HDL-C) is a reflection of plasma atherogenicity degree and indicator of small dense low-density lipoprotein (LDL). Small dense LDL is the best predictor for cardiovascular disease, but expensive and difficult to examined. The aim of this study to determine the correlation of AIP with stenosis level of the coronary artery in ACS. This research was an analytical study with cross-sectional design in 24 ACS patients meet the inclusion and exclusion criteria and conduct blood tests at the Central Laboratory Installation of Dr. M. Djamil Hospital Padang in January 2017- September 2017. Triglycerides and HDL-C performed by an enzymatic colorimetric method and stenosis level determined by coronary angiography. Spearman correlation was used to analyze correlation of atherogenic plasma index with stenosis level of the coronary artery, significant if p<0.05. The subjects of this study were 20 males (83.3%) and 4 females (16.6%) with mean age 57.6(7.9) years. The mean level of HDL cholesterol and triglycerides in ACS were 34.8 (8.7) mg/dL and 155.8 (51.8) mg/dL. The mean level of AIP in ACS was 0.28 (0.18). Median of stenosis level of coronary artery was 80% with range 50% - 95%. Spearman correlation test showed a moderate positive correlation between AIP with stenosis level of the coronary artery in ACS (r= 0.426 ; p<0.05). There is a moderate positive correlation between AIP with stenosis level of the coronary artery in ACS.
Downloads
References
PERKI. Pedoman tatalaksana sindrom koroner akut. Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. Ed 3., Jakarta, Kementerian Kesehatan Republik Indonesia, 2015; 1-45
Gomar FS, Quilis CP, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med, 2016; 4(13): 1-12.
WHO. Fact Sheet About Cardiovascular Disease. Downloaded from www.who.int/mediacentre/factsheets, accessed date 4 March 2017.
Kumar A, Cannon CP. Acute coronary syndromes: Diagnosis and management, part 1. Mayo Clin Proc Acute Coronary Syndromes, 2009; 84(10): 917-38.
Wong ND. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat. Rev. Cardiology, 2014; 11(5): 276-289.
Overbaugh KJ. Acute coronary syndrome. AJN, 2009; 109(5): 42-52.
Smith JN, Negrelli JM, Manek MB, Hawes EM, Viera AJ. Diagnosis and management of acute coronary syndrome: An evidence-based update. JABFM, 2015; 28(2): 283-92.
Andre R, Bongard V, Elosua R, Kirchberger I, Farmakis D, Hakkinen U. International differences in acute coronary syndromes patients' baseline characteristics, clinical management and outcomes in Western Europe: The EURHOBOP study. Heart, 2014; 100(15): 1-7.
Cunne CM, Kavanagh PM, Menown IA. A review of current diagnosis, investigation, and management of acute coronary syndromes in elderly patients. Cardiol Therapeutics, 2015; 4(2): 95-116.
Poon K & Walker D. Indication for coronary angiography advances. Intech, 2011; 33-68.
Samsuria IK, Adninta l. Pemeriksaan tingkat sdLDL serum sebagai petanda diagnostik stenosis koroner. IJCP, 2015; 22(1): 9-15.
Hartopo AB, Arso IA, Setianto BY. Low plasma atherogenic indrx associated with poor prognosis in hospitalized patients with acute myocardial inafarction. Acta Medica Indonesiana, 2016; 48(2): 106- 113.
Penalva RA, Huoya M, Correia LC, Feitosa GS, Ladeia AM. Lipid profile and severity of atherosclerotic disease in acute coronary syndrome. Arq Bras Cardiol, 2008; 90(1): 24-29.
Khazaal MS. Atherogenic index of plasma as a parameter in predicting cardiovascular risk in males compared to the conventional dyslipidemic indices (cholesterol ratio). Karbala J Med, 2013; 6(1): 1506-11.
Lafta MA. A comparative study for some atherogenic indices in sera of myocardial infarction, ischemic heart disease patients and control. Journal of Natural of Sciences Research, 2014; 4(8): 917-38.
Dobiasova M, Frohlich J, Sedova M, Cheung MC, Brown BG. Cholesterol esterification and atherogenic index ol plasma correlate with lipoprotein size and findings on coronary angiography. Journal of Lipid Research, 2011; 52(3): 566-573.
Bhardwaj S, Bhattacharjee J, Bhatnagar MK, Tyagi S. Atherogenic index of plasma, Castelli risk index and atherogenic coefficient-new parameters in assessing cardiovascular risk. Intern J of Pharmacy and Biological Sciences, 2013; 3(3): 359-364.
Susanti E, Donosepoetro M, Lawrence GS. Relations between atherogenic index plasma, ratio of small dense low-density lipoprotein/lecithin cholesterol acyltransferase and ratio of small dense low-density lipoprotein/cholesteryl ester transfer protein of controlled and uncontrolled type 2 diabetes mellitus. IBJ, 2009; 2: 38-44.
Ai M, Otokozawa S, Asztalos BF, Ito Y, Nakajima K, White CC, et al. Small dense LDL cholesterol and coronary heart disease: Results from the Framingham offspring study. Clinchem, 2010; 56(6): 967-76.
Nofer JR. Estrogen and atherosclerosis: Insight from animal models and cell systems. Journal of Molecular Endocrinology, 2012; 48(2): 13-29.
Hamm CW, Heeschen C, Falk E, Fox KA. Acute coronary syndromes: Pathophysiology, diagnosis and risk stratification. Downloaded from www.researchgate.net, 2014; 333-360.
Tiwari R, Changale SS, Iyer CM. Study of HbA1c as a biomarker in dyslipidemia and atherogenicity in type 2 diabetes mellitus. Int. J Clin and Biomed Res, 2015; 1(2): 5-11.
Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate in Apo-B-lipoprotein-depleted plasma (FERHDL). Clinchem, 2001; 34(7): 10-2.
